ELIZABETH HOPKINS: Open Payments
NPI 1720792724 · OWENTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 50 payments from 16 companies in 2025. Trend: 2023 $852 · 2024 $1,729 · 2025 $1,120
Food & beverage: $1,120
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $284 |
| Lilly USA, LLC | 8 | $126 |
| GlaxoSmithKline, LLC. | 6 | $94 |
| Novo Nordisk Inc | 5 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 4 | $71 |
| ABBVIE INC. | 4 | $68 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
Products named: BREZTRI, AIRSUPRA, TRELEGY ELLIPTA, JARDIANCE, XIFAXAN, VOQUEZNA, LAGEVRIO, Ozempic.
Industry payments across KY — which companies pay providers there.
